166 related articles for article (PubMed ID: 20358360)
21. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
[TBL] [Abstract][Full Text] [Related]
23. Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study.
Guillemin F; Martinez L; Calvert M; Cooper C; Ganiats T; Gitlin M; Horne R; Marciniak A; Pfeilschifter J; Shepherd S; Tosteson A; Wade S; Macarios D; Freemantle N
Osteoporos Int; 2013 Dec; 24(12):3001-10. PubMed ID: 23754200
[TBL] [Abstract][Full Text] [Related]
24. Non-participation in systematic screening for osteoporosis-the ROSE trial.
Rothmann MJ; Möller S; Holmberg T; Højberg M; Gram J; Bech M; Brixen K; Hermann AP; Glüer CC; Barkmann R; Rubin KH
Osteoporos Int; 2017 Dec; 28(12):3389-3399. PubMed ID: 28875257
[TBL] [Abstract][Full Text] [Related]
25. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
Roux C; Wyman A; Hooven FH; Gehlbach SH; Adachi JD; Chapurlat RD; Compston JE; Cooper C; Díez-Pérez A; Greenspan SL; Lacroix AZ; Netelenbos JC; Pfeilschifter J; Rossini M; Saag KG; Sambrook PN; Silverman S; Siris ES; Watts NB; Boonen S;
Osteoporos Int; 2012 Dec; 23(12):2863-71. PubMed ID: 22398855
[TBL] [Abstract][Full Text] [Related]
26. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
[TBL] [Abstract][Full Text] [Related]
27. Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
Amouzougan A; Deygat A; Trombert B; Constant E; Denarié D; Marotte H; Thomas T
Osteoporos Int; 2015 Dec; 26(12):2869-75. PubMed ID: 26104797
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study.
Kanterewicz E; Puigoriol E; García-Barrionuevo J; del Rio L; Casellas M; Peris P;
Osteoporos Int; 2014 May; 25(5):1455-64. PubMed ID: 24599272
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
[TBL] [Abstract][Full Text] [Related]
30. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
Siris ES; Miller PD; Barrett-Connor E; Faulkner KG; Wehren LE; Abbott TA; Berger ML; Santora AC; Sherwood LM
JAMA; 2001 Dec; 286(22):2815-22. PubMed ID: 11735756
[TBL] [Abstract][Full Text] [Related]
31. Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
FitzGerald G; Compston JE; Chapurlat RD; Pfeilschifter J; Cooper C; Hosmer DW; Adachi JD; Anderson FA; Díez-Pérez A; Greenspan SL; Netelenbos JC; Nieves JW; Rossini M; Watts NB; Hooven FH; LaCroix AZ; March L; Roux C; Saag KG; Siris ES; Silverman S; Gehlbach SH
J Clin Endocrinol Metab; 2014 Mar; 99(3):817-26. PubMed ID: 24423345
[TBL] [Abstract][Full Text] [Related]
32. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
Wang Y; Yu S; Hsu C; Tsai C; Cheng T
Osteoporos Int; 2020 Mar; 31(3):475-483. PubMed ID: 31696272
[TBL] [Abstract][Full Text] [Related]
33. Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia.
Růžičková O; Killinger Z; Kasalický P; Hamilton L; Tyl R; Tomková S; Kalouche-Khalil L
Adv Ther; 2018 Oct; 35(10):1713-1728. PubMed ID: 30191465
[TBL] [Abstract][Full Text] [Related]
34. Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women.
Tanaka S; Kuroda T; Saito M; Shiraki M
Osteoporos Int; 2013 Jan; 24(1):69-76. PubMed ID: 23229467
[TBL] [Abstract][Full Text] [Related]
35. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
[TBL] [Abstract][Full Text] [Related]
36. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study.
Kung AW; Fan T; Xu L; Xia WB; Park IH; Kim HS; Chan SP; Lee JK; Koh L; Soong YK; Soontrapa S; Songpatanasilp T; Turajane T; Yates M; Sen S
BMC Womens Health; 2013 Feb; 13():7. PubMed ID: 23410131
[TBL] [Abstract][Full Text] [Related]
38. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
39. Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS).
Cunha-Borges JL; Mier GM; Casas N; Medina A; Molina JF; García ML; Oliveria LG; Caselato MS; Cruz AC; Ippolito V; Flórez S
Adv Rheumatol; 2019 Nov; 59(1):46. PubMed ID: 31703737
[TBL] [Abstract][Full Text] [Related]
40. Ankle fractures do not predict osteoporotic fractures in women with or without diabetes.
Pritchard JM; Giangregorio LM; Ioannidis G; Papaioannou A; Adachi JD; Leslie WD
Osteoporos Int; 2012 Mar; 23(3):957-62. PubMed ID: 21562874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
